Silver Nanoparticle–Induced hMSC Proliferation Is Associated with HIF-1α-Mediated Upregulation of IL-8 Expression  by Jung, Sung Kyu et al.
4Department of Oncology-Pathology,
Karolinska Institute, Stockholm, Sweden;
5QIMR Berghofer Medical Research Institute,
Brisbane, Australia and 6Department of
Dermatology, LUMC, Leiden, The Netherlands
E-mail: goran_b.jonsson@med.lu.se
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online
version of the paper at http://www.nature.com/jid
REFERENCES
Balch CM, Gershenwald JE, Soong SJ et al. (2009)
Final version of 2009 AJCC melanoma staging
and classification. J Clin Oncol 27:6199–206
Curtin JA, Fridlyand J, Kageshita T et al. (2005)
Distinct sets of genetic alterations in mela-
noma. N Engl J Med 353:2135–47
Davies H, Bignell GR, Cox C et al. (2002) Muta-
tions of the BRAF gene in human cancer.
Nature 417:949–54
Goldstein AM, Chan M, Harland M et al. (2007)
Features associated with germline CDKN2A
mutations: a GenoMEL study of melanoma-
prone families from three continents. J Med
Genet 44:99–106
Harbst K, Staaf J, Lauss M et al. (2012) Molecular
profiling reveals low- and high-grade forms of
primary melanoma. Clin Cancer Res 18:
4026–36
Hayward NK (2003) Genetics of melanoma pre-
disposition. Oncogene 22:3053–62
Hodis E, Watson IR, Kryukov GV et al. (2012) A
landscape of driver mutations in melanoma.
Cell 150:251–63
Horn S, Figl A, Rachakonda PS et al. (2013) TERT
promoter mutations in familial and sporadic
melanoma. Science 339:959–61
Jardin F, Jais JP, Molina TJ et al. (2010) Diffuse
large B-cell lymphomas with CDKN2A
deletion have a distinct gene expression
signature and a poor prognosis under
R-CHOP treatment: a GELA study. Blood
116:1092–104
Jonsson G, Busch C, Knappskog S et al. (2010)
Gene expression profiling-based identification
of molecular subtypes in stage IV melanomas
with different clinical outcome. Clin Cancer
Res 16:3356–67
Puntervoll HE, Yang XR, Vetti HH et al. (2014)
Melanoma prone families with CDK4 germ-
line mutation: phenotypic profile and associa-
tions with MC1R variants. J Med Genet 50:
264–70
Robles-Espinoza CD, Harland M, Ramsay AJ et al.
(2014) POT1 loss-of-function variants predis-
pose to familial melanoma. Nat Genet
46:478–81
Scolyer RA, Long GV, Thompson JF (2011) Evol-
ving concepts in melanoma classification and
their relevance to multidisciplinary melanoma
patient care. Mol Oncol 5:124–36
Yokoyama S, Woods SL, Boyle GM et al. (2011) A
novel recurrent mutation in MITF predisposes
to familial and sporadic melanoma. Nature
480:99–103
Zebary A, Omholt K, van Doorn R et al. (2014)
Somatic BRAF and NRAS mutations in famil-
ial melanomas with known germline
CDKN2A status: a GenoMEL study. J Invest
Dermatol 134:287–90
Silver Nanoparticle–Induced hMSC Proliferation Is
Associated with HIF-1a-Mediated Upregulation of IL-8
Expression
Journal of Investigative Dermatology (2014) 134, 3003–3007; doi:10.1038/jid.2014.281; published online 7 August 2014
TO THE EDITOR
A recent study has reported that the
application of silver nanoparticles
(AgNPs) enhances wound healing (Tian
et al., 2007). Human mesenchymal stem
cells (hMSCs) could enhance normal
and impaired wound healing (Shin and
Peterson, 2013). A previous paper
showed that AgNPs might exert cyto-
toxic effects on hMSCs at high concen-
trations, but also induce cell activation
at subtoxic silver concentrations
(Greulich et al., 2009; Hackenberg
et al., 2011). Nonetheless, the effects
of AgNP-treated hMSCs in wound
healing remain unknown.
Rennekampff et al. (2000) reported
that IL-8 might be a growth factor for
the epithelium. It has been suggested
that AgNPs could contribute to wound
healing by increasing cell proliferation
via upregulation of IL-8 (Hackenberg
et al., 2011). However, there is a lack
of information on the regulatory mech-
anism of IL-8 in AgNP-treated hMSCs.
Hypoxia-inducible factor-1a (HIF-1a)
acts as transcription factor in regulating
metabolism, development, proliferation,
and pathology under hypoxic conditions
(Liu et al., 2013). Yu et al. (2007) also
demonstrated that wound healing in
diabetic patients is associated with an
increase in the synthesis of HIF-1a
protein. In this study, we investigated
the role of HIF-1a in AgNP-mediated
cell proliferation and IL-8 upregulation
in hMSCs.
The present study measured cell pro-
liferation and the expression of HIF-1a
and IL-8 in hMSCs treated with AgNPs.
In addition, this study investigated the
effect of small interfering RNA specific
for HIF-1a (HIF-1a siRNA) on cell pro-
liferation and IL-8 expression in hMSCs.
Polyvinylpyrrolidone-coated spherical
AgNPs (nanoComposix, San Diego,
CA) were used in this study. AgNPs
were characterized by transmission
electron microscopy before performing
the experiment (Figure 1a). The energy
diverse X-ray spectra demonstrated the
strong presence of Ag (Figure 1b). In
accordance with a previous study
(Hackenberg et al., 2011), AgNPs
increased cell proliferation in a dose-
dependent manner at subtoxic concen-
trations and decreased cell proliferation
at higher concentrations above
10mg ml1 (Figure 1c and e). As shown
in Figure 1d and f, a marked increase in
cell proliferation was observed after
treatment with AgNPs. To determine
the effect of AgNPs on IL-8 mRNA
expression, we treated hMSCs with
Accepted article preview online 7 July 2014; published online 7 August 2014
Abbreviations: AgNP, silver nanoparticle; hMSC, human mesenchymal stem cell; HIF-1a, hypoxia-
inducible factor-1a
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Figure 1. Silver nanoparticles (AgNPs) increase the proliferation of human mesenchymal stem cells (hMSCs) and the gene expression and production of IL-8 in
hMSCs. (a) Transmission electron microscopy images revealed that AgNPs had a spherical shape and measured 9.5±1.7 nm in diameter. (b) The energy diverse
X-ray (EDX) spectrum for the particle revealed the strong presence of silver (Ag). hMSCs were treated with various concentrations of AgNPs for 48 hours, and cell
proliferation was measured by CCK-8 (c) and BrdU (e) assays. Cells were also treated with 5mg ml 1 AgNPs for designated times, and cell proliferation was
measured by CCK-8 (d) and BrdU incorporation (f). (g) hMSCs were treated with various concentrations of AgNPs for 48 hours. Real-time PCR was performed to
analyze the changes in IL-8 gene expression. (h) hMSCs were treated with various concentrations of AgNPs for 48 hours and the amount of IL-8 released into the
culture supernatants was determined by ELISA. *Po0.05, **Po0.01. Each bar represents the mean±SD of three independent experiments.
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Figure 2. Knockdown of hypoxia-inducible factor-1a (HIF-1a) expression can attenuate the beneficial effects on skin wound healing mediated by silver
nanoparticle (AgNP)-treated hMSCs. (a) Human mesenchymal stem cells (hMSCs) were treated in the presence of various concentrations of AgNPs for 48 hours,
and the expression of HIF-1a in cell lysates was determined by western blot. (b) AgNPs induced the expression of HIF-1a protein in a dose-dependent manner.
(c) The expression of HIF-1a protein in lysates of hMSCs transfected with HIF-1a or control small interfering RNA (siRNA) constructs was measured by western
blotting. siRNA-treated hMSCs were treated with AgNPs for 48 hours. b-Actin was used as a loading control. (d) AgNP-mediated hMSCs proliferation was
diminished in hMSCs treated with HIF-1a siRNA. (e) hMSCs treated with HIF-1a siRNA were incubated in the presence of AgNPs for 48 hours, and the
concentration of IL-8 released into the culture supernatants was determined by ELISA. AgNP-induced IL-8 expression was reduced in hMSCs treated with HIF-1a
siRNA. (f) An E-PL3 digital camera (Olympus, Tokyo, Japan) was used to record images of wounds on days 0, 2, 4, 7, and 9. (g) The wound-healing rates were
evaluated using image analysis. Wound healing in AgNP-treated hMSCs with control siRNA mice was significantly increased on days 2, 4, 7, and 9, compared
with AgNP-treated hMSCs with HIF-1a siRNA (n¼6). *Po0.05, **Po0.01, NS, not significant, P40.05. Each bar shows the mean±SD from three separate
experiments. GFP, green fluorescence protein; PBS, phosphate-buffered saline.
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AgNPs for 24 hours and performed
real-time reverse transcription-PCR to
evaluate mRNA expression of IL-8. IL-
8 mRNA expression was signi-
ficantly increased in the hMSCs treated
with AgNPs (1, 2.5, 5, and 7.5mg)
compared with the untreated hMSCs
(Po0.05 for all comparisons;
Figure 1g). ELISA analysis also showed
that AgNP-induced IL-8 secretion
from hMSCs in a dose-dependent man-
ner (Figure 1h).
After exposure to AgNPs, the expres-
sion of HIF-1a protein in hMSCs incre-
ased in a dose-dependent manner
(Figure 2a and b). To investigate the
role of HIF-1a in AgNP-mediated upre-
gulation of IL-8 and cell proliferation in
hMSCs, we treated the cells additionally
with HIF-1a siRNA. As shown in
Figure 2c, expression of HIF-1a protein
in AgNP-treated hMSCs was signifi-
cantly reduced after HIF-1a siRNA treat-
ment, confirming that HIF-1a siRNA
effectively blocked the expression of
HIF-1a in these cells. The results
showed that AgNP-mediated hMSC pro-
liferation was decreased in hMSCs trea-
ted with HIF-1a siRNA (Figure 2d). We
measured AgNP-induced IL-8 expres-
sion in hMSCs that were transfected
with HIF-1a siRNA by ELISA and
demonstrated that IL-8 production was
also reduced following treatment with
HIF-1a siRNA (Figure 2e). Six-week-old
female C57BL/6 mice (Orientbio,
Sungnam, Korea) were maintained and
handled under protocols approved by
the Korea University Institutional Ani-
mal Care and Use Committee (KUIA-
CUC-2013-243). These mice averaged
18 g. The mice were divided into four
different groups, with six animals in
each group. Wounds were made on
the dorsal skin of each mouse using a
5 mm punch. According to their respec-
tive groups, the wound site was injected
with phosphate-buffered saline, hMSCs,
AgNP-treated hMSCs with HIF-1a
siRNA and AgNP-treated hMSCs with
control siRNA. Our preliminary studies
have shown that immunosuppressive
therapies were not needed in hMSCs
treatment. The wound areas were eval-
uated using image processing techni-
ques of Matlab (The MathWorks,
Natick, MA). This study showed that
AgNP-treated hMSCs could accelerate
cutaneous wound healing in vivo,
compared with untreated hMSCs
(Figure 2f and g). In addition, our find-
ings presented delayed wound closure
in the AgNP-treated hMSCs with
HIF-1a siRNA group compared with
the AgNP-treated hMSCs with control
siRNA group (Figure 2f and g). The
present results suggest that accelerated
wound closure by injecting with AgNP-
treated hMSCs may be HIF-1a depen-
dent. Histopathologic examination
demonstrated that hair growth and scar
formation might be major factors for the
effects of AgNP-treated hMSCs in
wound healing (Supplementary Figure
S1 online).
One study showed that hypoxic con-
ditions induce extracellular matrix
remodeling via HIF-1 in equine dermal
fibroblasts (Deschene et al., 2012). Du
et al. (2013) demonstrated that HIF-1a is
important for burn wound healing in a
mouse model through HIF-1a gene
therapy. Rezvani et al. (2011) showed
that HIF-1a could enhance the wound-
healing process in several ways,
including vascular endothelial growth
factor release and triggering the
mobilization of angiogenic cells.
Chang et al. (2013) demonstrated
that HIF-1a is important for MSC
survival under hypoxic conditions. In
addition, Razban et al. (2012) showed
that HIF-1a overexpression induced
angiogenesis pathways under hypoxic
conditions in MSCs. Forristal et al.
(2013) demonstrated that HIF-1a
protein stabilization increases hemato-
poietic stem cell quiescence and
accelerates blood recovery after
severe irradiation in vivo. In addition,
a previous study showed that
various aspects of stem cell biology,
such as differentiation and mobili-
zation, involve the HIF-1 signaling
pathway (Liu et al., 2011). Lim et al.
(2012) demonstrated that AgNPs
induced HIF-1a activation in
Caenorhabditis elegans. However, to
our knowledge, this is the first study
to elicit that AgNPs might induce
the expression of HIF-1a protein in
hMSCs.
The present study suggests that HIF-1a
may be a key factor in AgNP-induced
cell proliferation and IL-8 expression in
hMSCs. In view of these findings, HIF-
1a and the related downstream mole-
cules might be an important target of
research and development to improve
wound healing by using AgNP-treated
hMSCs.
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